Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03044782 · ClinicalTrials.gov registry record
Barriers to Care and QOL for CCCA Patients
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 34
- Enrollment target
NCT03044782: Completed study, sponsored by Northwestern University.
NCT03044782 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03044782 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
The purpose of the current project is twofold; first to determine what personal, historical, logistical, and environmental factors preclude women from obtaining medical care for CCCA hair loss. Because damage from CCCA is irreversible, early identification and treatment is paramount to limiting the negative ramifications of the disease. Second, to investigate how CCCA hair loss, a common occurrence in the Black population, can be a significant psychological impediment to lives of affected Black women. Based on previous research on the psychosocial impact of generalized hair loss in Black women, it is fair to consider that CCCA hair loss also leads to problems with self-esteem and participation in daily life activities. This research, the first of its kind, will add to existing knowledge of CCCA by investigating the quality of life and barriers to care of patients with this condition. The goal of this study is to illuminate what stands in the way of secondary and tertiary prevention of CCCA patients and tailor treatment strategies to address their needs. The results of this study will be instrumental in modifying dermatology resident training, adding to existing dermatology management guidelines, and even developing public health advocacy programming.
Interventions
- OTHER 53-Item Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-09 |
What the finished NCT03044782 record still lists
NCT03044782 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which 53-Item Survey is the first listed.
NCT03044782 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03044782 about?
NCT03044782 is a clinical study titled "Barriers to Care and QOL for CCCA Patients". The purpose of the current project is twofold; first to determine what personal, historical, logistical, and environmental factors preclude women from obtaining medical care for CCCA hair loss. Because damage from CCCA is irreversible, early identification and treatment is paramount to limiting the ...
What is the current status of trial NCT03044782?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2016-08. Estimated completion is 2017-09.
What interventions are being tested in trial NCT03044782?
The interventions under investigation include: 53-Item Survey (OTHER).
Who is sponsoring clinical trial NCT03044782?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia